These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 12974273)

  • 1. [Rate control or electrical cardioversion for persistent atrial fibrillation? Results of RACE].
    Liakishev AA
    Kardiologiia; 2003; 43(6):73-4. PubMed ID: 12974273
    [No Abstract]   [Full Text] [Related]  

  • 2. Electrical and pharmacologic cardioversion for atrial fibrillation.
    Kim SS; Knight BP
    Med Clin North Am; 2008 Jan; 92(1):101-20, xi. PubMed ID: 18061000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrical and pharmacologic cardioversion for atrial fibrillation.
    Kim SS; Knight BP
    Cardiol Clin; 2009 Feb; 27(1):95-107, ix. PubMed ID: 19111767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy and tolerability of commonly used agents to prevent recurrence of atrial fibrillation after successful cardioversion.
    Gonna H; Gallagher MM
    Am J Cardiovasc Drugs; 2014 Aug; 14(4):241-51. PubMed ID: 24604773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maintainance of sinus rhythm after electrical cardioversion of persistent atrial fibrillation.
    Burri H
    Eur Heart J; 2002 Apr; 23(7):586; author reply 586. PubMed ID: 11922651
    [No Abstract]   [Full Text] [Related]  

  • 6. Optimal timing of electrical cardioversion in patients with persistent atrial fibrillation.
    Naji F; Vokac D; Kanic V; Sabovic M
    Med Sci Monit; 2010 Oct; 16(10):CR464-8. PubMed ID: 20885349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral amiodarone increases the efficacy of direct-current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation.
    Capucci A; Villani GQ; Aschieri D; Rosi A; Piepoli MF
    Eur Heart J; 2000 Jan; 21(1):66-73. PubMed ID: 10610746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ibutilide in persistent atrial fibrillation refractory to conventional cardioversion methods.
    Naegeli B; Straumann E; Bertel O
    Int J Cardiol; 2005 Mar; 99(2):283-7. PubMed ID: 15749188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rate vs. rhythm control in patients with atrial fibrillation--an updated meta-analysis of 10 randomized controlled trials.
    Chen S; Dong Y; Fan J; Yin Y
    Int J Cardiol; 2011 Nov; 153(1):96-8. PubMed ID: 21963208
    [No Abstract]   [Full Text] [Related]  

  • 10. Intravenous amiodarone facilitates electrical cardioversion in patients with persistent atrial fibrillation pre-treated with oral amiodarone.
    Fernández PA; Bonato R; Galperin J; Sánchez RA; Garro HA; Acunzo R; Lago M; Elizari MV; Chiale PA
    Int J Cardiol; 2011 Sep; 151(2):230-1. PubMed ID: 21703705
    [No Abstract]   [Full Text] [Related]  

  • 11. CHA2DS2-VASc in the prediction of early atrial fibrillation relapses after electrical or pharmacological cardioversion.
    Falsetti L; Viticchi G; Tarquinio N; Silvestrini M; Capeci W; Balloni A; Catozzo V; Gentile A; Pellegrini F
    J Cardiovasc Med (Hagerstown); 2014 Aug; 15(8):636-41. PubMed ID: 24978663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of oral magnesium, alone or as an adjuvant to sotalol, after cardioversion in patients with persistent atrial fibrillation.
    Frick M; Darpö B; Ostergren J; Rosenqvist M
    Eur Heart J; 2000 Jul; 21(14):1177-85. PubMed ID: 10924301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretreatment of patients with atrial fibrillation who undergo electrical cardioversion.
    Stabile G; Turco P; De Simone A
    Circulation; 2003 Mar; 107(11):e75; author reply e75. PubMed ID: 12654622
    [No Abstract]   [Full Text] [Related]  

  • 14. [Current aspects of electrical cardioversion in patients with persistent atrial fibrillation].
    Mickley F; Löscher S; Hartmann A
    Med Klin (Munich); 2004 Jan; 99(1):18-23. PubMed ID: 14716481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of statins on preventing recurrence of atrial fibrillation after electrical cardioversion.
    García-Fernández A; Marín F; Mainar L; Roldán V; Martínez JG
    Am J Cardiol; 2006 Nov; 98(9):1299-300. PubMed ID: 17056354
    [No Abstract]   [Full Text] [Related]  

  • 16. Atrial fibrillation: rate versus rhythm control.
    Amani F; Smith ES
    J Ark Med Soc; 2005 Oct; 102(4):110-2. PubMed ID: 16265929
    [No Abstract]   [Full Text] [Related]  

  • 17. Left atrial and appendage mechanical function after pharmacological or electrical cardioversion in patients with chronic atrial fibrillation: a multicenter, randomized study.
    Mazzone C; Pandullo C; Scardi S; Salvi R; Miccio M; Cattarini G; Morgera T
    Ital Heart J; 2000 Feb; 1(2):128-36. PubMed ID: 10730613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rate control at least as effective as rhythm control for AF patients.
    Geriatrics; 2002 May; 57(5):63. PubMed ID: 12040594
    [No Abstract]   [Full Text] [Related]  

  • 19. [The electrical cardioversion of atrial fibrillation after 50 years since initial application: contemporary knowledge].
    Gilewski W; Sinkiewicz W
    Kardiol Pol; 2013; 71(7):757-63. PubMed ID: 23907913
    [No Abstract]   [Full Text] [Related]  

  • 20. [Success of pharmacologic cardioversion and electric cardioversion in patients with atrial fibrillation or flutter in a 5-year retrospective study].
    Bugán V; Renker B; Brunclík P; Baraniková D; Augustín E
    Vnitr Lek; 1994 Apr; 40(4):219-22. PubMed ID: 8184582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.